newsfilter
← Latest News
ACCESS Newswire·

Relief Therapeutics Reports Execution of Stipulation with NeuroRx and Jonathan Javitt to Continue Mediation Process

GENEVA, SWITZERLAND / ACCESSWIRE / April 5, 2022 / RELIEF THERAPEUTICS Holding SA ((SIX:RLF, OTCQB:RLFTF, RLFTY)) (" Relief "), today reported that it has entered into a stipulation to stay the proceedings in its pending litigation with NeuroRx, Inc. and